Church & Dwight (NYSE:CHD) Surprises With Q2 CY2026 Sales
Church & Dwight (NYSE:CHD) reported Q2 CY2026 sales of $1.53 billion, up 1.6% year on year and above analysts’ estimates by 1.8%, according to the company. Non-GAAP profit was $0.89 per share, in line with consensus. The firm said it is raising its sales, EPS, and cash flow outlook, and organic sales rose 5.8% y/y.
How this was made
The 30-second read
Why it matters
Q2 results show modest top-line growth with stronger organic growth (5.8% YoY) and a revenue beat, while the key offset is that next-quarter EPS guidance missed; the company also raised its outlook for sales, EPS, and cash flow.
Market read
Traders can reassess near-term expectations given the raised outlook versus the stated next-quarter EPS guidance miss, which can drive continued volatility after the initial reaction.
What to watch
The article does not quantify the raised outlook or the magnitude of the EPS guidance miss, limiting conviction on how much the market will re-rate the stock.
Background
Church & Dwight is a household and personal care products company known for Arm & Hammer baking soda, with power brands driving organic growth.
Ticker impact
Church & Dwight reported Q2 CY2026 sales up 1.6% to $1.53B and raised its outlook for sales, EPS, and cash flow.
Bias modestly positive with potential volatility around the guidance miss and raised outlook details.
The text provides concrete Q2 revenue and EPS-in-line results plus an explicit outlook raise, while also noting EPS guidance for next quarter missed, which can cap upside despite the beat.
Market effects
Supports the consumer staples narrative that power brands can gain share even in a challenging macro.
No specific regional demand or FX details beyond general macro volatility.
No explicit international segment or FX driver disclosed in the text.
Counterpoint
The revenue beat may not translate into sustained earnings momentum if the next-quarter EPS guidance miss reflects margin or cost pressures.
Key entities
- companyChurch & Dwight
Reported Q2 CY2026 sales of $1.53B, non-GAAP EPS of $0.89, and raised its outlook; stock rose 1.2% to $98.88 immediately after reporting.
